Shopping Cart
- Remove All
- Your shopping cart is currently empty
PPARγ agonist 4 (Compound 18b), a potent and selective PPARγ agonist, demonstrates antitumor efficacy only when used in conjunction with Imatinib and does not exhibit cytotoxic effects on either non-resistant or resistant cells [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | PPARγ agonist 4 (Compound 18b), a potent and selective PPARγ agonist, demonstrates antitumor efficacy only when used in conjunction with Imatinib and does not exhibit cytotoxic effects on either non-resistant or resistant cells [1]. |
Molecular Weight | 387.45 |
Formula | C24H22FN3O |
Cas No. | 2380227-06-3 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.